Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721)
Securities code: Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721) securities abbreviation: ST Baihua Announcement No.: 2022007 Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721)
Suggestive announcement on the reduction of more than 1% of the company’s shares by shareholders holding more than 5%
The board of directors, all directors and relevant shareholders of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
1. This equity change is within the reduction plan and does not touch the tender offer.
2. After this equity change, the proportion of shares held by Mr. Zhang Xiaoqing in the listed company decreased from 8.68% to 7.30%, and the equity change proportion was 1.38%.
3. This equity change will not lead to changes in the controlling shareholders and actual controllers of the company.
Mr. Zhang Xiaoqing, the shareholder of the company, received the notice of unlimited reduction of shares held by the company from November 2021 to February 2023 through the auction of shares held by the Shanghai Stock Exchange, accounting for 38% of the total shares of the company from November 2021 to February 2023. The changes in equity are hereby announced as follows:
1、 Basic information of this equity change
Name: Zhang Xiaoqing
Meaning of information disclosure
Address: Building 9, No. 19, emeiling, Gulou District, Nanjing, Jiangsu Province
Service person
Changes in equity from November 23, 2021 to March 1, 2022
Change method change date share reduction share reduction proportion type (share)
Block transaction of equity change: November 23, 202139295001.05%
-March 1, 2022 A shares
Bidding transaction 12513570.33%
Total 51808571.38%
Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721)
Zhang Xiaoqing himself reduced his shareholding of the company by 1% from November 23, 2021 to February 28, 2022. 2、 Before and after this equity change, information disclosure obligors owned shares of the company
Name of shareholder before and after the change of share nature
Number of shares (shares) shareholding ratio number of shares (shares) shareholding ratio
Zhang Xiaoqing unlimited sale of tradable shares
32,576489 8.68% 27,395632 7.30%
Total 325764898.68% 273956327.30%
3、 Follow up matters involved
1. This equity change is a reduction of holdings and does not touch the tender offer.
2. In addition to 689500 shares reduced through block trading on November 23, 2021, the remaining 4491357 shares were reduced to fulfill the share reduction plan. For details, see the company’s announcement on Shanghai Stock Exchange (www.sse. Com. CN.) on December 4, 2021 Announcement of Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721) shareholders’ share reduction plan (Announcement No.: 2021080) disclosed.
3. This equity change is the reduction of non largest shareholder holding more than 5%, which will not change the controlling shareholder and actual controller of the company.
4. This change in shareholders’ equity does not involve the disclosure of equity change report by the information disclosure obligor.
5. After this equity change, the information disclosure obligor is still in the implementation period of its shareholding reduction plan. The company will continue to urge it to strictly implement the relevant provisions on shareholding reduction and disclose relevant information to investors in time. Please pay attention to investment risks.
It is hereby announced.
Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721) board of directors March 2, 2022
